Home > Healthcare & Medical Devices > Hemostasis Products Market

Hemostasis Products Market Size By Product (Topical Hemostasis Product {Gelatin, Polysaccharides , Oxidized Regenerated Cellulose, Collagen}), Infusible Hemostasis Products {Platelet Concentrate From Donor Blood, Fresh Frozen Plasma (FFP), Factor VIII, Prothrombin}), Advanced Hemostasis Products ({Flowable, Thrombin, Synthetic Sealants, Fibrin}), By Application (Trauma, Surgery, Hemophilia, Myocardial Infarction), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030

  • Report ID: GMI5287
  • Published Date: Jul 2022
  • Report Format: PDF

Industry Overview

Hemostasis Products Market size surpassed 1.5 billion in 2021 and is poised to register 5.5% CAGR between 2022 and 2030 due to the increasing prevalence of cardiac disorders across the globe.

Hemostasis Products Market

Get more details on this report - Request Free Sample PDF

According to the data provided by World Health Organization (WHO), nearly 17.9 million people die annually due to cardiovascular diseases. Furthermore, rising incidence of trauma and accident cases are estimated to further impel the global market growth. According to official statistics, approximately 42,915 people died from motor vehicle traffic crashes in the U.S. in the year 2021.

Technological advancements in hemostasis products will further offer unprecedented growth opportunities to the hemostasis products industry over the forecast period. For instance, in February 2022, Futura Surgicare Pvt Ltd under a new vertical, Dolphin Hemostats widen its product portfolio under the name Hemostax (Oxidised Regenerated Cellulose). The product is developed to assist surgeons in managing bleeding more efficaciously being an absorbable hemostat.

During COVID-19 pandemic, hemostasis products market faced a setback due to disturbances experienced in supply-chain operations and manufacturing because of lockdown for precautions coupled with stringent regulations enforced by governing authorities worldwide.

In May 2020, as per the study published in the Journal of hematology, titled "Pandemic care: The need for hemostasis testing in critically ill COVID-19 patients", patients treated in hospitals for COVID-19 tend to have an inflammatory response such as hypercoagulability, that refers to risk of developing pathological blood clots in the bloodstream, also known as thrombosis or venous thromboembolism (VTE).

The process of preventing or slowing down the blood flow to promote wound healing is called hemostasis. There are multiple types of hemostatic products such as gauze-based products that are largely used for wound-packing of a penetrating injury. Development of such products will stimulate the hemostasis products market growth.

A sudden surge in accident and trauma cases will augment the hemostasis products market statistics

An increase in accident and trauma cases across the globe will drive the hemostasis products market growth. For instance, according to the World Health Organization (WHO), both violence related trauma and unintentional injuries account for about 4.4 million deaths across the globe each year. Growing number of surgeries will further add to the market growth.

Owing to high rise in incidence of chronic diseases that require surgeries, the need for hemostats has elevated in recent years. Any surgical procedure can develop severe complications and result into uncontrollable bleeding. Therefore, a rise in accident and trauma cases coupled with increase in surgical procedures will create lucrative opportunities for hemostasis products market expansion over the coming years.

Increasing number of surgical procedures worldwide will fuel the industry landscape

Global Hemostasis Products Market, By Product

Get more details on this report - Request Free Sample PDF

Hemostasis products market by product is segmented into topical, infusible, and advanced hemostasis products. The topical hemostasis products are further sub-segmented into gelatin, polysaccharides, oxidized regenerated cellulose, collagen. Whereas, the infusible hemostasis products are sub-divided into platelet concentrate from donor blood, fresh frozen plasma (FFP), factor VIII, and prothrombin. The advanced hemostasis products include flowable, thrombin, synthetic sealants, and fibrin.

The topical hemostasis products segment held largest market share of more than 70% in 2021 and is anticipated to witness significant growth during the forecast period as these products are one of the most preferred and widely used products in surgical settings. Topical hemostasis products are cost effective, efficient, easy to use, and also biodegradable in nature. Thus, increasing number of surgical procedures will favour the segmental growth in foreseeable future.

Increasing prevalence of cardiac disorders among population globally will support the product demand

Global Hemostasis Products Market, By Application,

Get more details on this report - Request Free Sample PDF

Hemostasis products market by application is segmented into trauma, surgery, hemophilia, myocardial infarction, and others. The myocardial infarction segment held over 20.0% market share in 2021 and is anticipated to witness substantial growth during the forecast period. Rise in cardiovascular disease prevalence globally owing to sedentary lifestyle, unhealthy eating habits, excessive intake of alcohol, and smoking are primary factors driving the market growth.

Moreover, as per the National Centres for Disease Control and Prevention (CDC), chronic diseases such as myocardial infarction are the leading cause of death in U.S. accounting for nearly USD 3.8 trillion annual health care expenses. Thus, the growing prevalence of chronic conditions will drive forward the segmental growth.

High investment in healthcare sector development by government authorities will stimulate the market demand

Get more details on this report - Request Free Sample PDF

Hemostasis products market by end-use is segmented into hospitals, ambulatory surgical centres and others. The hospitals segment is projected to witness over 5.5% CAGR during the 2022 to 2030 period. Increasing expenditure on development of healthcare facilities in order to provide easy accessibility of medical care to the people will positively impact the overall market outlook.

Moreover, growth of medical tourism sector coupled with high investment made by government of various countries towards growth of healthcare sector will propel the growth and development of hospital segment. Growing geriatric population base susceptible to suffer from various chronic conditions, requiring treatment and surgeries will generate lucrative opportunities for hemostasis products market over the projected timeline.

Development of technologically advanced hemostasis products in the region will drive the market forecasts

North America Hemostasis Products Market, By Country

Get more details on this report - Request Free Sample PDF

North America held over 30% revenue share of overall market in 2021. Presence of major market players, favourable reimbursement scenarios, rising number of medical centres and growing investment in development of hemostasis products will result into rapid adoption of hemostasis products throughout the region. Moreover, increasing trauma cases and road accidents are some of the key factors driving the hemostasis products market share.

According to World Health Organization (WHO) data, one of the topmost causes of death among people aged between 5-29 years is road traffic accidents. New product launch along with development of advanced hemostasis products will stimulate the market expansion over the upcoming period.

An upsurge in number of product launches and strategic partnerships will lead to expansion of the market

Global hemostasis products industry consists of numerous players. Few of these players are Medtronic, Johnson & Johnson, Baxter International, Pfizer, Becton, Dickinson, and Company (BD), B. Braun Melsungen AG, Tricol Biomedical, Hemostasis LLC, Teleflex Incorporated, CuraMedical BV, among various others. These players are actively involved in technological advancements and strategic collaboration in order to expand their product portfolio as well as customer base.

Some of the recent industry developments:

  • In July 2021, Baxter Healthcare Corporation, a subsidiary of Baxter International Inc. acquired certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc. The strategy helped the company to enhance its product portfolio across the hospitals and gain new customers
  • In February 2020, Terumo launched AQUABRID, a new surgical sealant in the EMEA market. The product is designed to stop bleeding during the surgical procedure

The hemostasis products market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2022 to 2030 for the following segments:

By Product

  • Topical hemostasis products
    • Gelatin
    • Polysaccharides
    • Oxidized regenerated cellulose
    • Collagen
  • Infusible hemostasis products
    • Platelet concentrate from donor blood
    • Fresh frozen plasma (FFP)
    • Factor VIII
    • Prothrombin
  • Advanced hemostasis products
    • Flowable
    • Thrombin
    • Synthetic sealants
    • Fibrin

By Application

  • Trauma
  • Surgery
  • Hemophilia
  • Myocardial infarction
  • Others

By End-use

  • Hospitals
  • Ambulatory surgical centers
  • Others

The above information is provided for the following regions and countries:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Others
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Others


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global hemostasis products industry size was valued at more than USD 1.5 billion in 2021 and will register a 5.5% CAGR during the forecast period of 2022-2030.

The topical hemostasis products segment held over 70% of the global market share in 2021 because these products are efficient, cost-effective, easy-to-use, and biodegradable.

North America captured more than 30% of global hemostasis products industry share in 2021 because of various factors, such as favorable reimbursement policies, presence of reputed companies, and rising investments in the production of hemostasis products.

Johnson & Johnson, Medtronic, Baxter International, Becton, Dickinson & Co., Pfizer, B. Braun Melsungen AG, and Hemostasis LLC, among many others, are the leading market participants.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2021
  • Companies covered: 18
  • Tables & Figures: 334
  • Countries covered: 17
  • Pages: 207

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount